questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Voies d'administration de substances chimiques et des médicaments
Injections
Injections sous-cutanées
Injections intradermiques
Injections intradermiques : Questions médicales fréquentes
Diagnostic
5
Tests diagnostiques
Injections intradermiques
Réaction cutanée
Injections intradermiques
Sensibilisation
Tuberculose
Immunosuppression
Tests diagnostiques
Symptômes
5
Réaction cutanée
Démangeaisons
Réaction allergique
Difficultés respiratoires
Allergies
Réaction cutanée
Prévention
5
Infections cutanées
Prévention
Antécédents médicaux
Complications
Professionnels de santé
Sécurité
Traitements
5
Antihistaminiques
Corticostéroïdes
Réaction allergique
Intervention médicale
Soins des plaies
Infection
Complications
5
Infection
Réaction cutanée
Cicatrices
Injections intradermiques
Réaction anaphylactique
Urgence médicale
Immunodépression
Allergies
Facteurs de risque
5
Médicaments
Réactions indésirables
Antécédents médicaux
Réactions allergiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Injections intradermiques : Questions médicales les plus fréquentes",
"headline": "Injections intradermiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Injections intradermiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2026-02-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Injections intradermiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Injections sous-cutanées",
"url": "https://questionsmedicales.fr/mesh/D007279",
"about": {
"@type": "MedicalCondition",
"name": "Injections sous-cutanées",
"code": {
"@type": "MedicalCode",
"code": "D007279",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.530.620"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Injections intradermiques",
"alternateName": "Injections, Intradermal",
"code": {
"@type": "MedicalCode",
"code": "D007271",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nader Pazyar",
"url": "https://questionsmedicales.fr/author/Nader%20Pazyar",
"affiliation": {
"@type": "Organization",
"name": "Dermatology Department, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran."
}
},
{
"@type": "Person",
"name": "Chao Wang",
"url": "https://questionsmedicales.fr/author/Chao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China."
}
},
{
"@type": "Person",
"name": "Sakiko Shimizu",
"url": "https://questionsmedicales.fr/author/Sakiko%20Shimizu",
"affiliation": {
"@type": "Organization",
"name": "R&D Department, Alliance Division, General Hospital Company, TERUMO CORPORATION, Japan."
}
},
{
"@type": "Person",
"name": "Eriko Itoh",
"url": "https://questionsmedicales.fr/author/Eriko%20Itoh",
"affiliation": {
"@type": "Organization",
"name": "R&D Department, Alliance Division, General Hospital Company, TERUMO CORPORATION, Japan."
}
},
{
"@type": "Person",
"name": "Yoichiro Iwase",
"url": "https://questionsmedicales.fr/author/Yoichiro%20Iwase",
"affiliation": {
"@type": "Organization",
"name": "R&D Department, Alliance Division, General Hospital Company, TERUMO CORPORATION, Japan. Electronic address: Yoichiro_Iwase@terumo.co.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37240448",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109094"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37908349",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1276255"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Intradermal Administration Volume Using a Hollow Microneedle on the Pharmacokinetics of Fluorescein Isothiocyanate Dextran (M.W. 4,000).",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37165148",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11095-023-03529-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy and safety of methylene blue injection for intractable idiopathic pruritus ani: a single-arm metaanalysis and systematic review.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37306793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10151-023-02825-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intradermal injection of Cutibacterium acnes and staphylococcus: A pustular acne-like murine model.",
"datePublished": "2024-04-05",
"url": "https://questionsmedicales.fr/article/38581133",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jocd.16279"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Voies d'administration de substances chimiques et des médicaments",
"item": "https://questionsmedicales.fr/mesh/D004333"
},
{
"@type": "ListItem",
"position": 5,
"name": "Injections",
"item": "https://questionsmedicales.fr/mesh/D007267"
},
{
"@type": "ListItem",
"position": 6,
"name": "Injections sous-cutanées",
"item": "https://questionsmedicales.fr/mesh/D007279"
},
{
"@type": "ListItem",
"position": 7,
"name": "Injections intradermiques",
"item": "https://questionsmedicales.fr/mesh/D007271"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Injections intradermiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Injections intradermiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Injections intradermiques",
"description": "Comment se déroule un test intradermique ?\nQuels tests utilisent des injections intradermiques ?\nQuelle est la réaction normale à une injection intradermique ?\nComment interpréter une réaction positive ?\nQuels sont les risques d'un faux négatif ?",
"url": "https://questionsmedicales.fr/mesh/D007271#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Injections intradermiques",
"description": "Quels symptômes peuvent apparaître après une injection intradermique ?\nQuand consulter un médecin après une injection ?\nLes symptômes d'une infection sont-ils possibles ?\nComment différencier une réaction normale d'une allergie ?\nLes symptômes peuvent-ils varier selon le vaccin ?",
"url": "https://questionsmedicales.fr/mesh/D007271#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Injections intradermiques",
"description": "Comment prévenir les réactions allergiques ?\nQuelles précautions avant une injection intradermique ?\nLes antécédents médicaux influencent-ils les injections ?\nComment choisir un professionnel pour l'injection ?\nDes recommandations pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D007271#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Injections intradermiques",
"description": "Quel traitement pour une réaction allergique ?\nComment traiter une infection post-injection ?\nY a-t-il un traitement pour la douleur au site d'injection ?\nComment gérer une réaction sévère ?\nDes soins locaux sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D007271#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Injections intradermiques",
"description": "Quelles sont les complications possibles ?\nComment reconnaître une infection post-injection ?\nLes cicatrices sont-elles fréquentes ?\nQuelles sont les réactions graves possibles ?\nLes complications sont-elles plus fréquentes chez certains patients ?",
"url": "https://questionsmedicales.fr/mesh/D007271#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Injections intradermiques",
"description": "Quels facteurs augmentent le risque d'infection ?\nLes allergies préexistantes sont-elles un facteur de risque ?\nL'âge influence-t-il les risques d'injection ?\nLe type de médicament injecté joue-t-il un rôle ?\nLes antécédents de réactions allergiques sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D007271#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se déroule un test intradermique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un petit volume de solution est injecté dans la peau pour évaluer la réaction."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent des injections intradermiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de tuberculose et d'allergies sont couramment réalisés par cette méthode."
}
},
{
"@type": "Question",
"name": "Quelle est la réaction normale à une injection intradermique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une légère rougeur et un gonflement local sont des réponses normales."
}
},
{
"@type": "Question",
"name": "Comment interpréter une réaction positive ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réaction positive indique une sensibilisation à l'antigène testé, comme la tuberculose."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'un faux négatif ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faux négatif peut survenir en cas d'immunosuppression ou de technique incorrecte."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après une injection intradermique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, démangeaisons ou douleur au site d'injection sont fréquents."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin après une injection ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez si vous avez une réaction sévère comme un gonflement important ou des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection sont-ils possibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection peut se manifester par une rougeur accrue, du pus ou de la fièvre."
}
},
{
"@type": "Question",
"name": "Comment différencier une réaction normale d'une allergie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une allergie provoque des symptômes plus graves comme un œdème ou des éruptions cutanées étendues."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier selon le vaccin ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de vaccin administré."
}
},
{
"@type": "Question",
"name": "Comment prévenir les réactions allergiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les allergènes connus et informez le professionnel de santé de vos allergies."
}
},
{
"@type": "Question",
"name": "Quelles précautions avant une injection intradermique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Assurez-vous que le site d'injection est propre et que vous n'avez pas d'infections cutanées."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils les injections ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informez votre médecin de vos antécédents médicaux pour éviter des complications."
}
},
{
"@type": "Question",
"name": "Comment choisir un professionnel pour l'injection ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisissez un professionnel de santé qualifié et expérimenté pour minimiser les risques."
}
},
{
"@type": "Question",
"name": "Des recommandations pour les enfants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Assurez-vous que l'enfant est calme et informez-le sur la procédure pour réduire l'anxiété."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une réaction allergique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques ou des corticostéroïdes peuvent être prescrits pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection post-injection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement antibiotique peut être nécessaire si une infection est confirmée."
}
},
{
"@type": "Question",
"name": "Y a-t-il un traitement pour la douleur au site d'injection ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques en vente libre peuvent aider à soulager la douleur locale."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction sévère ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de réaction sévère, une intervention médicale immédiate est nécessaire."
}
},
{
"@type": "Question",
"name": "Des soins locaux sont-ils recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, garder le site propre et sec aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des réactions allergiques et des cicatrices."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection post-injection ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Recherchez une rougeur accrue, du pus ou une douleur persistante au site d'injection."
}
},
{
"@type": "Question",
"name": "Les cicatrices sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cicatrices peuvent se former, surtout si l'injection est mal réalisée."
}
},
{
"@type": "Question",
"name": "Quelles sont les réactions graves possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions anaphylactiques peuvent survenir, nécessitant une attention médicale urgente."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains patients ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés ou avec des antécédents d'allergies sont à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli ou une mauvaise hygiène au site d'injection augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les allergies préexistantes sont-elles un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des allergies sont plus susceptibles de réagir aux injections."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les risques d'injection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes enfants et les personnes âgées peuvent avoir des réactions différentes aux injections."
}
},
{
"@type": "Question",
"name": "Le type de médicament injecté joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments sont plus susceptibles de provoquer des réactions indésirables."
}
},
{
"@type": "Question",
"name": "Les antécédents de réactions allergiques sont-ils importants ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique de réactions allergiques augmente le risque de complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/02/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Dermatology Department, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Rehabilitation Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
R&D Department, Alliance Division, General Hospital Company, TERUMO CORPORATION, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
R&D Department, Alliance Division, General Hospital Company, TERUMO CORPORATION, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
R&D Department, Alliance Division, General Hospital Company, TERUMO CORPORATION, Japan. Electronic address: Yoichiro_Iwase@terumo.co.jp.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, the Netherlands.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, the Netherlands. K.van_der_Maaden@lumc.nl.
Department of Immunology, Leiden University Medical Center, 2300RC, Leiden, the Netherlands. K.van_der_Maaden@lumc.nl.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, CoMIT 0603, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Medical Device Division, Innovation and Business Development Headquarters, Daicel Corporation, Minato-ku, Tokyo, Japan. Electronic address: kz_terai@jp.daicel.com.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Drs. Dezfuly and Molavi are Assistants of Dermatology with the Department of Dermatology at Imam Khomeini Hospital at Ahvaz Jundishapur University of Medical Sciences in Ahvaz, Iran.
Publications dans "Injections intradermiques" :
2 publications dans cette catégorie
Affiliations :
Dr. Hadibarhaghtalab and Ms. Parvar are with the Molecular Dermatology Research Center at Shiraz University of Medical Sciences in Shiraz, Iran.
Publications dans "Injections intradermiques" :
Current worldwide mRNA vaccination against SARS-CoV-2 by intramuscular injection using a needled syringe has greatly protected numerous people from COVID-19. An intramuscular injection is generally we...
Gold nanoparticles (GNPs) have been used in the development of novel therapies as a way of delivery of both stimulatory and tolerogenic peptide cargoes. Here we report that intradermal injection of GN...
Hollow microneedles (hMNs) have been gaining attention as a tool to enable the intradermal (i.d.) administration of pharmaceutical products. However, few reports have examined the effect of administra...
FD-4 solution was injected i.d. using a hMN or injected s.c. with a 27 G needle. Pharmacokinetics and dermatokinetics of FD-4 were analyzed using a compartment model. The skin distribution of iodine, ...
With the administered drug assumed to be absorbed from the broad injection site into blood vessels in the upper and lower dermis by rapid (k...
The drug distribution in the skin may be related to the obtained pharmacokinetics parameters suggested that the number of needles in the MN system and the total administration volume should be conside...
To evaluate how effective methylene blue injection was at treating intractable idiopathic pruritus ani....
A comprehensive literature search of the PubMed, Embase, Cochrane library, and Web of Science databases was conducted. All clinical studies (prospective and retrospective) that evaluated the efficacy ...
The seven selected studies included 225 patients with idiopathic pruritus ani. The resolution rates after a single injection and after a second injection was 0.761 (0.649-0.873, P < 0.01, I...
Using methylene blue injections to treat intractable idiopathic pruritus ani is relatively efficacious, resulting in a relatively low recurrence rate and no severe complications. However, the availabl...
Skin 16S microbiome diversity analysis indicates that the Staphylococcus genus, especially Staphylococcus aureus (S. aureus), plays a crucial role in the inflammatory lesions of acne. However, current...
The aim is to develop a mouse model for acne, establishing an animal model that more closely mimics the clinical presentation of pustular acne. This will provide a new research platform for screening ...
Building upon the existing combination of acne-associated Cutibacterium acnes (C. acnes) with artificial sebum, we will inject a mixture of S. aureus and C. acnes locally into the dermis in a 3:7 rati...
We found that the acne animal model with mixed bacterial infection better replicates the dynamic evolution process of human pustular acne. Compared to the infection with C. acnes alone, mixed bacteria...
This model can reflect the clinical symptoms and development of human pustular acne, overcoming the limitations of animal models commonly used in basic research to study this situation. It provides su...
Protein therapeutics are essential in the treatment of various diseases, but most of them require parenteral administration. Since intravenous and subcutaneous injections are associated with discomfor...
Diabetes is one of the most common causes of neuropathy. Morbidity and mortality increase in patients suffering from diabetic polyneuropathy and are experienced by approximately 10 to 54% of diabetic ...
This narrative systematic review aimed to evaluate the effectiveness of intradermal BTX-A injection on painful diabetic neuropathy. The queried databases included PubMed, EMBASE, Cochrane Central Regi...
In a review of 4 RCTs and 1 case-control study on the effectiveness of BTX-A in reducing the pain of diabetic neuropathy, 273 patients were evaluated in total. The lowest and highest number of subject...
The results of this systematic review demonstrated that intradermal injection of BTX-A causes significant and long-term (up to 12 weeks) improvement in diabetic neuropathy pain. The improvement in sle...
Exosomes have gained attention for their potential in skin rejuvenation. Currently, most exosome products are available for topical administration, and the use of subdermal injection as a route of adm...
The purpose of this case report is to describe a case of skin necrosis that occurred following an intradermal injection of lyophilized exosomes....
We hereby report a case of a middle-aged man who experienced adverse effects after receiving an intradermal injection of lyophilized exosomes. Multiple injections of an exosome product were administer...
There are few reports available regarding complications, especially those related to intradermal exosomes. These complications include multiple foreign-body granulomatous reactions at the injection si...
Utilizing exosomes through unapproved methods should be avoided due to the possibility of adverse reactions that could cause aesthetic issues....
Botulinum toxin has played a remarkable role in management of forehead wrinkles. Most used is intramuscular technique due to its deposition into the muscles, however, with adverse effects like brow pt...
This study included a clinical trial of 32 facial halves divided equally into intradermal and intramuscular injection technique groups, receiving total dose of 8 U. Results were assessed by clinical e...
Results showed least mean for objective wrinkle rate in intramuscular group, showing statistically significant improvement. Overall improvement in eyebrow height and eyebrow movement were slightly mor...
Among intradermal and intramuscular botulinum toxin injection technique, the effect and potency were better for intramuscular technique, whereas the patient comfort and compliance were better for intr...
Recent advancements in androgenetic alopecia (AGA) treatment have highlighted the efficacy of botulinum toxin (BoNT). However, inconsistencies in injection sites and depths warrant attention. It remai...
This split-scalp randomized controlled trial divided each enrolled participant's scalp along the midline: one side was randomized to receive intramuscular BoNT injections in the surrounding muscles, w...
Twenty-nine patients completed the study, with significant improvements in hair density observed in the intramuscular injection group compared to the intradermal group (p < 0.001). Both groups exhibit...
Our research revealed that both BoNT injection strategies enhanced hair diameter 12 weeks post-treatment, with intramuscular injections significantly improving hair density more effectively. Despite t...
ChiCTR2400080190....